Skip to main content
. 2022 Mar 1;27(5):1636. doi: 10.3390/molecules27051636

Table 5.

Predicted ADMET for Jusanin and reference.

Comp. BBB Level a Solubility Level Absorption Level CYP2D6 Prediction b PPB Prediction c
Jusanin V. low good good non inhibitor >90%
Simeprevir V. low low V. poor non inhibitor >90%

a BBB level, blood–brain barrier penetration level; b CYP2D6, cytochrome P2D6 inhibition; c PBB, plasma protein binding level.